Listed

Standard Biotools Inc.: Form 10-Q for the period ended Sep 30, 2011

Filed with the SEC on Nov 14, 2011 and accepted by EDGAR at Nov 14, 2011, 16:40 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2011-07-01 to 2011-09-30$10.6mus-gaap:Revenues
Revenue9 months2011-01-01 to 2011-09-30$29.9mus-gaap:Revenues
Cost of revenue3 months2011-07-01 to 2011-09-30$3.3mus-gaap:CostOfGoodsSold
Cost of revenue9 months2011-01-01 to 2011-09-30$9.2mus-gaap:CostOfGoodsSold
Research and development3 months2011-07-01 to 2011-09-30$3.3mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2011-01-01 to 2011-09-30$9.9mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2011-07-01 to 2011-09-30$8.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2011-01-01 to 2011-09-30$23.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2011-07-01 to 2011-09-30−$4.1mus-gaap:OperatingIncomeLoss
Operating income9 months2011-01-01 to 2011-09-30−$15.6mus-gaap:OperatingIncomeLoss
Interest expense3 months2011-07-01 to 2011-09-30$439.0kus-gaap:InterestExpense
Interest expense9 months2011-01-01 to 2011-09-30$2.7mus-gaap:InterestExpense
Income tax3 months2011-07-01 to 2011-09-30$20.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2011-01-01 to 2011-09-30$130.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2011-07-01 to 2011-09-30−$4.5mus-gaap:NetIncomeLoss
Net income9 months2011-01-01 to 2011-09-30−$19.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2011-07-01 to 2011-09-30−$0.22us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2011-01-01 to 2011-09-30−$1.70us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2011-01-01 to 2011-09-30−$15.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2011-01-01 to 2011-09-30$997.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2011-09-30$11.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-09-30$76.0mus-gaap:AssetsCurrent
Total assetsAt period end2011-09-30$82.6mus-gaap:Assets
Current liabilitiesAt period end2011-09-30$19.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2011-09-30$23.5mus-gaap:Liabilities
Long-term debtAt period end2011-09-30$3.0mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2011-09-30$8.6mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2011-09-30$59.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-11-311107. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.